Novo Nordisk in the Philippines has been at the forefront of innovative diabetes care. By accelerating prevention, providing access to affordable care, and introducing innovative ways to manage ...

As Heart Month reminds us of the critical need to protect our cardiovascular and metabolic (CVM) health, Novo Nordisk Philippines and the Philippine College of Endocrinology, Diabetes, and ...

Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991. View on euronews ...

Novo Nordisk said Tuesday it will slash the list prices of several of its popular pre-filled insulin pens and vials by up to 75%, becoming the latest drugmaker to reduce the cost of the critical ...

Novo Nordisk, a Danish drugmaker, announced it will cut some insulin prices in the United States up to 75% next year, amid pressure from competitors and lawmakers. The drugmaker will lower ...

Novo Nordisk will invest $4.1 billion to develop a new manufacturing facility in the U.S., which will be used to boost production for the company’s weight loss and diabetes drugs Wegovy and ...

Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions. Novo Nordisk is not just trying to make ...

Robert Hart is a London-based Forbes senior reporter. Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss ...

Novo Nordisk expects its GLP-1 drugs Wegovy and Ozempic to soon come off the Food and Drug Administration’s official shortage list, CEO Lars Fruergaard Jørgensen told Barron’s on Wednesday.

Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared. But the Danish pharmaceutical company's origins were motivated by ...